التفاصيل البيبلوغرافية
| العنوان: |
Glucagon-like Peptide-1 Receptor Agonists and Diabetic Kidney Disease: From Bench to Bed-Side. |
| المؤلفون: |
Abdelrahman, Aly M., Awad, Alaa S., Hasan, Irtiza, Abdel-Rahman, Emaad M. |
| المصدر: |
Journal of Clinical Medicine; Dec2024, Vol. 13 Issue 24, p7732, 14p |
| مصطلحات موضوعية: |
GLUCAGON-like peptide-1 receptor, DIABETIC nephropathies, TYPE 2 diabetes, GLUCAGON-like peptide-1 agonists, PEOPLE with diabetes |
| مستخلص: |
Glucagon-like peptide-1 (GLP-1) receptor agonists are currently available for the management of type 2 diabetes mellitus. They have been shown to help with diabetic kidney diseases through multiple mechanisms. In this review, we will shed light on the different mechanisms of action through which GLP-1 receptor agonists may achieve their roles in renal protection in diabetics, both in animal and human studies, as well as review the renal outcomes when using these drugs and their safety profile in diabetic patients. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Clinical Medicine is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder